These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
179 related items for PubMed ID: 22161581
1. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with vincristine and ticlopidine. Barabash-Neila R, García-Rodríguez E, Bernabeu-Wittel J, Bueno-Rodríguez I, Ramírez-Villar G, López-Gutierrez JC. Indian J Pediatr; 2012 Oct; 79(10):1386-7. PubMed ID: 22161581 [No Abstract] [Full Text] [Related]
2. Image Gallery: Kaposiform haemangioendothelioma. Moscarella E, Ametrano O, Diplomatico M, De Chiara C, Capasso M, Errico ME, Picciocchi R. Br J Dermatol; 2017 Jun; 176(6):e124. PubMed ID: 28581217 [No Abstract] [Full Text] [Related]
6. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: successful treatment with embolization and vincristine in two newborns. Garcia-Monaco R, Giachetti A, Peralta O, Napoli N, Lobos P, Gioseffi L, Mariani G. J Vasc Interv Radiol; 2012 Mar; 23(3):417-22. PubMed ID: 22365299 [Abstract] [Full Text] [Related]
7. Successful treatment of Kaposiform hemangioendothelioma with everolimus. Uno T, Ito S, Nakazawa A, Miyazaki O, Mori T, Terashima K. Pediatr Blood Cancer; 2015 Mar; 62(3):536-8. PubMed ID: 25306933 [Abstract] [Full Text] [Related]
8. Successful Management of Pancreatic Kaposiform Hemangioendothelioma With Sirolimus: Case Report and Literature Review. Wang C, Li Y, Xiang B, Li F, Chen S, Li L, Ji Y. Pancreas; 2017 Mar; 46(5):e39-e41. PubMed ID: 28426496 [No Abstract] [Full Text] [Related]
9. Successful treatment of Kasabach-Merritt syndrome arising from kaposiform hemangioendothelioma by systemic corticosteroid therapy and surgery. Jiang RS, Hu R. Int J Clin Oncol; 2012 Oct; 17(5):512-6. PubMed ID: 21947597 [Abstract] [Full Text] [Related]
10. Low dose sirolimus treatment for refractory tufted angioma and congenital kaposiform hemangioendothelioma, both with Kasabach-Merritt phenomenon. Mariani LG, Schmitt IR, Garcia CD, Kiszewski AE. Pediatr Blood Cancer; 2019 Aug; 66(8):e27810. PubMed ID: 31087627 [No Abstract] [Full Text] [Related]
11. Kaposiform hemangioendothelioma with Kasabach-Merritt phenomenon: from vincristine to sirolimus. Jahnel J, Lackner H, Reiterer F, Urlesberger B, Urban C. Klin Padiatr; 2012 Oct; 224(6):395-7. PubMed ID: 23070861 [No Abstract] [Full Text] [Related]
12. Kaposiform hemangioendothelioma: therapeutic efficacy for an enigmatic diagnosis. Blei F. Pediatr Blood Cancer; 2015 Apr; 62(4):551-2. PubMed ID: 25559734 [No Abstract] [Full Text] [Related]
13. Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up. Wang Z, Li K, Yao W, Dong K, Xiao X, Zheng S. Pediatr Blood Cancer; 2015 Apr; 62(4):577-80. PubMed ID: 25346262 [Abstract] [Full Text] [Related]
17. Sirolimus for treatment of Kaposiform haemangioendothelioma with Kasabach-Merritt phenomenon: a retrospective cohort study. Zhang G, Chen H, Gao Y, Liu Y, Wang J, Liu XY. Br J Dermatol; 2018 May 23; 178(5):1213-1214. PubMed ID: 29388191 [No Abstract] [Full Text] [Related]